evidence: Understanding COVID-19 in children: immune determinants and post-infection conditions [...] Ouldali, N. et al. Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: a national post-authorization pharmacovigilance study. Lancet Reg. Health Eur.17, 100393 (2022). [...] Zambrano, L. D. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12–18 years — United States, July–December 2021. MMWR Morb. Mortal. Wkly. Rep.71, 52–58 (2022).